Mexico's drug policy reform: cutting edge success or crisis in the making?
| dc.contributor.affiliation | Division of Global Public Health, Department of Medicine, University of California, San Diego, United States; BC Centre for Excellence in HIV/AIDS, Vancouver, Canada | es_ES |
| dc.contributor.email | sstrathdee@ucsd.edu | es_ES |
| dc.creator | Werb, Dan | |
| dc.creator | Medina Mora, María Elena | |
| dc.creator | Beletsky, Leo | |
| dc.creator | Rafful, Claudia | |
| dc.creator | Mackey, Tim | |
| dc.creator | Arredondo, Jaime | |
| dc.creator | Strathdee, Steffanie A. | |
| dc.creator.identificador | "http://orcid.org/0000-0001-9300-0752">Medina Mora, María Elena | es_ES |
| dc.creator.identificador | "0000-0003-0083-7276">Rafful, Claudia | es_ES |
| dc.date.accessioned | 2017-06-29T03:59:28Z | |
| dc.date.accessioned | 2026-03-27T14:33:22Z | |
| dc.date.available | 2017-06-29T03:59:28Z | |
| dc.date.issued | 2014 | es_ES |
| dc.date.published | 2014 | es_ES |
| dc.description.month | Sep | es_ES |
| dc.identifier | 2828 | es_ES |
| dc.identifier.citation | Juan Carlos Bautista Ramírez | es_ES |
| dc.identifier.doi | 10.1016/j.drugpo.2014.05.014 | es_ES |
| dc.identifier.eissn | 1873-4758 | es_ES |
| dc.identifier.issn | 0955-3959 | es_ES |
| dc.identifier.numero | 5 | es_ES |
| dc.identifier.organizacion | Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz | es_ES |
| dc.identifier.paginacion | 823-825 | es_ES |
| dc.identifier.place | Países Bajos | es_ES |
| dc.identifier.uri | https://doi.org/10.1016/j.drugpo.2014.05.014 | es_ES |
| dc.identifier.uri | https://pubmed.ncbi.nlm.nih.gov/24974368/ | es_ES |
| dc.identifier.uri | https://repositorio.inprf.gob.mx/handle/123456789/4677 | |
| dc.identifier.volumen | 25 | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Amsterdam ; New York : Elsevier | es_ES |
| dc.relation | 25 (5) 823-825 p. | es_ES |
| dc.relation | versión del editor | es_ES |
| dc.relation.jnabreviado | INT J DRUG POLICY | es_ES |
| dc.relation.journal | International Journal of Drug Policy | es_ES |
| dc.rights | acceso cerrado | es_ES |
| dc.subject.ko | Drug and Narcotic Control-Legislation & jurisprudence | es_ES |
| dc.subject.ko | Health Care | es_ES |
| dc.subject.ko | Reform-Legislation & jurisprudence | es_ES |
| dc.subject.ko | Health Policy-Legislation & jurisprudence | es_ES |
| dc.subject.ko | Humans | es_ES |
| dc.subject.ko | Mexico | es_ES |
| dc.subject.mesh | Drug and Narcotic Control/legislation and jurisprudence | es_ES |
| dc.subject.mesh | Health Care Reform/legislation and jurisprudence | es_ES |
| dc.subject.mesh | Health Policy/legislation and jurisprudence | es_ES |
| dc.subject.mesh | Humans | es_ES |
| dc.subject.mesh | Mexico | es_ES |
| dc.title | Mexico's drug policy reform: cutting edge success or crisis in the making? | es_ES |
| dc.type | artículo | es_ES |
